Delivery of atropine complexed with hydroxypropyl beta‐cyclodextrin via a contact lens
Optometry and Vision Science · 2026-11 · 103 (11)
DOI: 10.1002/ovs2.70115 ↗Kurz gefasst
Fachartikel in der Zeitschrift Optometry and Vision Science, online erschienen am 09.11.2026. Verfasst von Md Abdullah Aziz und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Optometry and Vision Science, University of New South Wales, Sydney, New South Wales, Australia. Hauptthemen laut MEDLINE: Atropine, 2-Hydroxypropyl-beta-cyclodextrin, Drug Delivery Systems, Myopia. Die Arbeit nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Scientia PhD Scholarship.
Abstract (Originalsprache)
Purpose
Myopia is a global vision problem linked to a significant economic burden and potential blindness in severe cases. Current interventions—including atropine eye drops, contact lenses, spectacles, and lifestyle changes—are often combined due to limited individual effectiveness. This study aimed to develop and stabilize atropine formulations, load them into contact lenses, and evaluate atropine release profiles.
Methods
Atropine sulfate was converted to atropine base and complexed with 2‐hydroxypropyl beta‐cyclodextrin (HPBCD) in phosphate‐buffered saline (PBS) at pH 6.5 or 7.4. Formulation stability was monitored over one year at room temperature (21°C) using high‐performance liquid chromatography (HPLC). Etafilcon A and omafilcon A lenses were soaked in the formulations for 24 hours. The amount of atropine base loaded and released was quantified via HPLC, and toxicity was assessed according to ISO 10993‐5.
Results
After 1 year, the formulations retained 97.3% (pH 6.5) and 80.3% (pH 7.4) of atropine base. At pH 6.5, etafilcon A and omafilcon A absorbed 3.2 ± 0.1 μg and 1.7 ± 0.6 μg of atropine base, respectively. Etafilcon A released 100% of the atropine base within 4 hours, and omafilcon A released 59% within 2 hours. Contact lens eluates showed no toxicity.
Conclusions
These findings support the stability and safety of atropine base formulations for potential ocular drug delivery.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- School of Optometry and Vision Science, University of New South Wales, Sydney, New South Wales, Australia.
- Department of Pharmacy, Jashore University of Science and Technology, Jashore, Bangladesh.
- School of Chemistry, University of Sydney, Sydney, New South Wales, Australia.
ORCID-Profile: Md Abdullah Aziz, Furqan Maulvi, Kishor Mazumder, Alex Hui, Fiona Stapleton, Mark Willcox
Förderung
- Scientia PhD Scholarship
Zitieren
APA
Aziz, M. A., Maulvi, F., Kuppusamy, R., Mazumder, K., Hui, A., Stapleton, F., & Willcox, M. (2026). Delivery of atropine complexed with hydroxypropyl beta‐cyclodextrin via a contact lens. Optometry and Vision Science, 103(11). https://doi.org/10.1002/ovs2.70115
Vancouver
Aziz MA, Maulvi F, Kuppusamy R, Mazumder K, Hui A, Stapleton F, et al. Delivery of atropine complexed with hydroxypropyl beta‐cyclodextrin via a contact lens. Optometry and Vision Science. 2026;103(11). doi:10.1002/ovs2.70115
BibTeX
@article{Aziz2026,
author = {Aziz, Md Abdullah and Maulvi, Furqan and Kuppusamy, Rajesh and Mazumder, Kishor and Hui, Alex and Stapleton, Fiona and Willcox, Mark},
title = {Delivery of atropine complexed with hydroxypropyl beta‐cyclodextrin via a contact lens},
journal = {Optometry and Vision Science},
year = {2026},
volume = {103},
number = {11},
doi = {10.1002/ovs2.70115}
}
EUVIMED